Clinical Trials Directory

Trials / Completed

CompletedNCT01489293

Inhibitory Receptors in Eosinophils of Atopic Subjects

Characterization of the Expression and Activity of Inhibitory Receptors Such as CLM-1 in Eosinophils of Atopic Subjects

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to analyze the expression and activity of inhibitory molecules on eosinophils obtained from allergic subjects.

Conditions

Timeline

Start date
2012-05-01
Primary completion
2013-12-31
Completion
2013-12-31
First posted
2011-12-09
Last updated
2018-03-22

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01489293. Inclusion in this directory is not an endorsement.